[Pharmacoeconomic analysis of gefitinib therapy in patients with non-cell cell lung cancer].
Protsenko SA, Rudakova AV, Moiseenko FV, Levchenko EV, Matsko DE, Ivantsov AO, Semënov II, Ievleva AG, Mitiushkina NV, Togo AV, Novik AV, Imianitov EN, Moiseenko VM.
Protsenko SA, et al. Among authors: imianitov en.
Vopr Onkol. 2012;58(3):352-8.
Vopr Onkol. 2012.
PMID: 22888650
Russian.